Judge Rules Pradaxa Lawsuits Can Go Directly to Federal Court
The Web´s largest source for information on Pradaxa legal news, research and side effects is available at the Pradaxa Resource Center. Visit http://www.Pradaxa-lawsuits.org
Dallas, TX (PRWEB) October 20, 2012
The Journal for The American Medical Association last month warned that the FDA may have rushed approval of the drug Pradaxa, overlooking key Pradaxa side effects like early trials showing there was no reversal agent for Pradaxa internal bleeding.
The news comes after an FDA warning on December 7, 2011 that it was investigating Pradaxa after receiving more injury or death reports than expected. USA Today reported on August 19th that the FDA received 3,781 reports of side effects and 542 deaths among Pradaxa users last year, leading all other medications in 2011.
Now, a federal judge overseeing Pradaxa lawsuits filed by those injured has entered an order expediting the claim filing process. On October 4, 2012, Judge David Herndon entered a Case Management Order allowing for direct filing of claims into the Pradaxa Federal MDL (http://www.ilsd.uscourts.gov/opinions/ilsd_live.3.12.md.2385.2171747.0.pdf#search=%22pradaxa%22).
Anyone affected by internal bleeding or the loss of a loved one after using Pradaxa is urged to speak with a lawyer about their legal rights as soon as possible.
Pradaxa is a popular blood thinner prescribed to prevent strokes and blood clots in patients with atrial fibrillation. According to The Wall Street Journal on April 24, 2012, Boehringer Ingelheim has earned more than $1 billion from the drug so far in more than 70 countries.
Due to the number of Pradaxa lawsuits expected, a central court was recently established in Illinois to handle the claims. The case is known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. On September 5, 2012, the United States Judicial Panel on Multidistrict Litigation indicated more than 100 Pradaxa claims have now been filed.
On July 24th, Judge David Herndon issued an order denying attempts by Boehringer Ingelheim to dismiss Pradaxa bleeding lawsuits. http://www.ilsd.uscourts.gov/opinions/ilsd_live.3.12.cv.611.2107129.0.pdf#search=%22pradaxa%22
Anyone affected by internal bleeding after Pradaxa use is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of these federal MDL cases, the Pradaxa Resource center only recommends lawyers who are already handling Pradaxa lawsuits.
To speak with a lawyer, or for more information on the research, warnings, side effects and legal options relating to the drug Pradaxa, visit http://www.Pradaxa-lawsuits.org.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebpradaxa-lawsuit/pradaxa-bleeding/prweb10035102.htm